‘Cervavac’ Gets WHO’s ‘Seal’ — India’s First Homegrown HPV Vaccine Wins Global Recognition
Serum Institute of India has secured WHO prequalification for Cervavac — its 32nd such certification. The recombinant vaccine shields ages 9–26 against four HPV types, and UN agencies can now buy it for immunisation drives in the developing world.
